Skip to content

The Savvy Diabetic | Blog

Visit the post for more.

  • By Joanne Milo
  • Based in United States of America
  • Roughly one post per week
  • First post on

Posts per month

Data for this chart is available in the table below
Posts per month
Month starting Posts
Nov 2022 1
Dec 2022 5
Jan 2023 6
Feb 2023 9
Mar 2023 5
Apr 2023 6
May 2023 7
Jun 2023 6
Jul 2023 5
Aug 2023 6
Sep 2023 4
Oct 2023 6
Nov 2023 4
Dec 2023 3
Jan 2024 9
Feb 2024 4
Mar 2024 5
Apr 2024 5
May 2024 4
Jun 2024 4
Jul 2024 5
Aug 2024 4
Sep 2024 5
Oct 2024 4
Nov 2024 3

Any gaps could be due to errors when fetching the blog’s feed.

Most recent posts

Savvy Updates 11/18/24: NovoNordisk Phasing Out Human Insulin Pens, Sequel/Twiist AID, History of Artificial Pancreas
Novo Nordisk says it is gradually phasing out human insulin pens globally by Maggie Fick for Reuters.com, 14 November 2024. Novo Nordisk is gradually ending production of human insulin pens, as it spends billions to …
On , by thesavvydiabetic, 89 words
Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design
Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered …
On , by thesavvydiabetic, 99 words
Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires
In this week’s issue of The Savvy Diabetic: Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta …
On , by thesavvydiabetic, 132 words